Moreover, given the impact of this cytokine for adaptive immune system activation, it might be suggested IFN also as a vaccine adjuvant for enhancing effective anti-viral protective response for especially individuals with obesity. The gene discussed is IFNA1; the disease is obesity due to melanocortin 4 receptor deficiency.